Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 50 | 56 | +6 |
| Shares | 2.48M | 2.88M | +401.1K (+16.2%) |
| Value | $11.9M | $21.2M | +$9.31M (+78.2%) |
New holders (11)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| J. Goldman & Co LP | 148,738 | $1.10M | 0.08% |
| Simplex Trading, LLC | 39,896 | $294.0K | 0.01% |
| Jump Financial, LLC | 23,400 | $173.0K | 0.01% |
| Sentinus, LLC | 22,500 | $166.0K | 0.10% |
| Franklin Resources Inc | 20,709 | $153.0K | 0.00% |
| Acadian Asset Management LLC | 15,763 | $115.0K | 0.00% |
| Goldman Sachs Group Inc | 10,055 | $74.0K | 0.00% |
| Citigroup Inc | 7,629 | $56.0K | 0.00% |
| Hazlett, Burt & Watson, Inc. | 200 | $1.00K | 0.00% |
| Royal Bank of Canada | 57 | $0 | 0.00% |
| Axiom Investment Management LLC | 5 | $0 | 0.00% |
Sold out (5)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 31,484 | $151.0K |
| Two Sigma Securities, LLC | 12,624 | $61.0K |
| Captrust Financial Advisors | 166 | $1.00K |
| Banque Cantonale Vaudoise | 309 | $1.00K |
| Steward Partners Investment Advisory, LLC | 100 | $0 |